Skip to main content
Caplight Logo









Sonablate Corp.

Sonablate Corp.

Private
Charlotte, North CarolinaHealthcare & Life Scienceshttps://www.sonablate.com/

Last Round

Early Funding

Aug 6, 2026

Total Funding Raised

$73M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Sonablate Corp. is a medical device company that develops and manufactures high-intensity focused ultrasound (HIFU) technologies for the ablation of prostate tissue.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

high-intensity focused ultrasoundHIFUprostate ablationfocal therapyrobotic surgeryminimally invasive surgeryimage-guided therapyurology medical deviceprostate cancer treatmentprecision medicineurology roboticssurgical roboticsmedical capital equipmentAI-assisted surgerynon-invasive prostate surgery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Sonablate Corp. Comparables

Compare Sonablate Corp. with similar companies based on industry and business-model similarity.

Sonablate Corp. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
EDAP TMS
85%
Profound Medical Corp
83%
Francis Medical
81%

Sonablate Corp. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingAug 6, 2026
SeedJul 1, 2021
DebtAug 3, 2017

Key People

Founding team and executive leadership

Richard Yang

Chief Executive Officer, Board Member, CEO And BOD

Executive Team

Ralf Seip

Chief Technology Officer

Executive Team

Sonablate Corp. Investors

Notable investors and investment history

Sonablate Corp. investors
InvestorRounds
Hercules CapitalVC Round
Decathlon Capital PartnersVC Round, Debt
Eleven VenturesEarly Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 6, 2026

    $200M raised, led by Eleven Ventures.

  • Jul 27, 2026

    Open roles increased to 89, 5.2x the trailing average.

Sonablate Corp. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Sonablate Corp. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Sonablate Corp.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersCharlotte, North Carolina
Employee Range82
Year Founded2004
Last FundingAug 6, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?